Home/Filings/4/0001437749-21-028320
4//SEC Filing

Margolin Richard A 4

Accession 0001437749-21-028320

CIK 0001742927other

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 4:31 PM ET

Size

5.5 KB

Accession

0001437749-21-028320

Insider Transaction Report

Form 4
Period: 2021-12-08
Transactions
  • Award

    Stock Option (right to buy)

    2021-12-08+5,3005,300 total
    Exercise: $3.78Exp: 2031-12-07Common Stock, par value $0.0001 per share (5,300 underlying)
Footnotes (1)
  • [F1]The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The Option will vest at the rate of one hundred percent (100%) of the shares subject thereto upon the one year anniversary of the date of grant, provided that Awardee remains a director of the Company through such vesting date. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan.

Issuer

REVIVA PHARMACEUTICALS HOLDINGS, INC.

CIK 0001742927

Entity typeother

Related Parties

1
  • filerCIK 0001822761

Filing Metadata

Form type
4
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:31 PM ET
Size
5.5 KB